Coronavirus Delta Plus Variant Prevention: What you can do to protect yourself from Delta Plus variant, as per experts
![COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619703711/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=WB8tj9FiBVgpCnJxtaqj0TT3Gnf4tWIM)
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma
![COVID-19 India FAQs: What is Delta Plus, Why It's a Variant of Concern, Can Vaccines Fight It and More | The Weather Channel - Articles from The Weather Channel | weather.com COVID-19 India FAQs: What is Delta Plus, Why It's a Variant of Concern, Can Vaccines Fight It and More | The Weather Channel - Articles from The Weather Channel | weather.com](https://s.w-x.co/util/image/w/in-coronavirus_41.jpg?crop=16:9&width=480&format=pjpg&auto=webp&quality=60)
COVID-19 India FAQs: What is Delta Plus, Why It's a Variant of Concern, Can Vaccines Fight It and More | The Weather Channel - Articles from The Weather Channel | weather.com
![DNA Explainer: Difference between Delta and Delta Plus variants - Symptoms, treatment, who's at risk DNA Explainer: Difference between Delta and Delta Plus variants - Symptoms, treatment, who's at risk](https://cdn.dnaindia.com/sites/default/files/styles/full/public/2021/06/28/982251-coronavirus-delta-plus-variant.jpg)
DNA Explainer: Difference between Delta and Delta Plus variants - Symptoms, treatment, who's at risk
![NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins | National Institutes of Health (NIH) NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2020/20200508-covid-19.jpg)
NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins | National Institutes of Health (NIH)
![Delta Plus Variant: What is Delta+ Covid? Its Symptoms in India. Why Has it Become Variant of Concern? Delta Plus Variant: What is Delta+ Covid? Its Symptoms in India. Why Has it Become Variant of Concern?](https://static.india.com/wp-content/uploads/2021/06/coronavirus-4972480_1280.jpg?impolicy=Medium_Resize&w=1200&h=800)
Delta Plus Variant: What is Delta+ Covid? Its Symptoms in India. Why Has it Become Variant of Concern?
![Baricitinib plus remdesivir shows promise for treating COVID-19 | National Institutes of Health (NIH) Baricitinib plus remdesivir shows promise for treating COVID-19 | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2020/20201211-covid.jpg?itok=GwUKbKQV×tamp=1607709840)
Baricitinib plus remdesivir shows promise for treating COVID-19 | National Institutes of Health (NIH)
![New 'Delta Plus' variant of SARS-CoV-2 identified. Is it a concern for India? - Coronavirus Outbreak News New 'Delta Plus' variant of SARS-CoV-2 identified. Is it a concern for India? - Coronavirus Outbreak News](https://akm-img-a-in.tosshub.com/indiatoday/images/story/202106/Covid_spike_protein__Getty_Ima_1200x768.jpeg?9xlgnu5xcLoVXFJOWbqR.XLHGJSCVpg0&size=770:433)